**Question:** Which of the following is most useful for reversing severe ergot induced vasospasm?

A. Nitroglycerin
B. Verapamil
C. Diltiazem
D. Naloxone

**Core Concept:**
Ergotism is a rare but potentially life-threatening complication of ergot alkaloid intake, often seen in the context of hallucinogenic drug use (e.g., LSD) or accidental ingestion (e.g., in food poisoning from ergot-contaminated grains). Ergot alkaloids, such as those found in the LSD-25 molecule, cause vasospasm by binding to alpha-adrenergic receptors, leading to constriction of blood vessels and resulting ischemia.

**Why the Correct Answer is Right:**
B. Verapamil

Verapamil is a calcium channel blocker, which works by inhibiting the influx of calcium ions into the smooth muscle cells of blood vessels. By blocking calcium entry, verapamil prevents the contraction of smooth muscle and, consequently, reduces vasoconstriction. In the context of severe ergot-induced vasospasm, verapamil helps to reverse the vasoconstriction caused by ergot alkaloids binding to alpha-adrenergic receptors.

**Why Each Wrong Option is Incorrect:**

A. Nitroglycerin: Nitroglycerin is a nitrate drug that works by reducing the sensitivity of vascular smooth muscle to noradrenaline, thereby reducing vasoconstriction. However, its primary mechanism does not directly oppose the effects of ergot alkaloids, as it does not target calcium channels or alpha-adrenergic receptors.

B. Diltiazem: Diltiazem is another calcium channel blocker, similar to verapamil. However, it has been shown to be less effective than verapamil in reversing ergot-induced vasospasm due to its lower potency in blocking calcium channels.

C. Naloxone: Naloxone is a specific antagonist of opioid receptors and is primarily used for reversal of opioid-induced respiratory depression. It does not target alpha-adrenergic receptors or calcium channels, rendering it ineffective in reversing ergot-induced vasospasm.

**Clinical Pearl:**

Verapamil is the most effective choice among the options provided for reversing ergot-induced vasospasm. Its mechanism of action directly antagonizes the effects of ergot alkaloids on alpha-adrenergic receptors and calcium channels, making it a suitable agent for treating severe ergot-induced vasospasm.